Skip to content
10-K

Annual Report

RIGEL PHARMACEUTICALS INC RIGL

0001034842-26-000015

← back to feed
Filed
Mar 3, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 25, 2026 18.47M sh
Shares Diluted FY 2025 · Dec 31, 2025 18.84M sh
Shares Diluted FY 2025 · Dec 31, 2024 17.69M sh
Shares Diluted restated FY 2025 · Dec 31, 2023 17.4M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 $75.66M
Operating Cash Flow FY 2025 · Dec 31, 2024 $31.47M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$5.74M
Long Term Debt FY 2025 · Dec 31, 2025 $52.5M
Short Term Investments FY 2025 · Dec 31, 2025 $114.38M
Short Term Investments FY 2025 · Dec 31, 2024 $20.58M
Cash And Equivalents FY 2025 · Dec 31, 2025 $40.58M
Cash And Equivalents FY 2025 · Dec 31, 2024 $56.75M
Stockholders Equity FY 2025 · Dec 31, 2025 $391.48M
Stockholders Equity FY 2025 · Dec 31, 2024 $3.29M
Stockholders Equity FY 2025 · Dec 31, 2023 −$28.64M
Stockholders Equity FY 2025 · Dec 31, 2022 −$13.62M
Current Liabilities FY 2025 · Dec 31, 2025 $99.24M
Current Liabilities FY 2025 · Dec 31, 2024 $63.3M
Total Liabilities FY 2025 · Dec 31, 2025 $122.11M
Total Liabilities FY 2025 · Dec 31, 2024 $160.69M
Current Assets FY 2025 · Dec 31, 2025 $240.17M
Current Assets FY 2025 · Dec 31, 2024 $135.1M
Total Assets FY 2025 · Dec 31, 2025 $513.59M
Total Assets FY 2025 · Dec 31, 2024 $163.98M
Eps Diluted FY 2025 · Dec 31, 2025 $19.48
Eps Diluted FY 2025 · Dec 31, 2024 $0.99
Eps Diluted restated FY 2025 · Dec 31, 2023 −$1.44
Eps Basic FY 2025 · Dec 31, 2025 $20.40
Eps Basic FY 2025 · Dec 31, 2024 $0.99
Eps Basic restated FY 2025 · Dec 31, 2023 −$1.44
Sga Expense FY 2025 · Dec 31, 2025 $115.9M
Sga Expense FY 2025 · Dec 31, 2024 $113.06M
Sga Expense FY 2025 · Dec 31, 2023 $105.74M
Rd Expense FY 2025 · Dec 31, 2025 $33.3M
Rd Expense FY 2025 · Dec 31, 2024 $23.38M
Rd Expense FY 2025 · Dec 31, 2023 $24.52M
Net Income FY 2025 · Dec 31, 2025 $367.02M
Net Income FY 2025 · Dec 31, 2024 $17.49M
Net Income FY 2025 · Dec 31, 2023 −$25.09M
Operating Income FY 2025 · Dec 31, 2025 $125.47M
Operating Income FY 2025 · Dec 31, 2024 $24.19M
Operating Income FY 2025 · Dec 31, 2023 −$20.49M
Cost Of Revenue FY 2025 · Dec 31, 2025 $19.62M
Cost Of Revenue FY 2025 · Dec 31, 2024 $18.65M
Cost Of Revenue FY 2025 · Dec 31, 2023 $7.11M
Revenue FY 2025 · Dec 31, 2025 $294.28M
Revenue FY 2025 · Dec 31, 2024 $179.28M
Revenue FY 2025 · Dec 31, 2023 $116.88M